Survodutide 10mg × 10
Research-use disclaimer
All products are strictly for laboratory research and in-vitro studies, not for human consumption.
Description
Survodutide (abbreviated as SUR) is a GLP-1/glucagon dual receptor agonist used for fat reduction and weight management. It helps reduce body weight by suppressing appetite and promoting energy expenditure.
Effects
Suppresses appetite, reduces calorie intake; promotes energy expenditure, accelerates fat breakdown; improves insulin sensitivity, assists blood sugar control; reduces body weight and waist circumference; decreases visceral fat accumulation.
Usage
Subcutaneous injection, initial dose of 0.5 mg once weekly, increase every 4 weeks based on tolerance, maximum recommended dose 4.5 mg once weekly; specific dosage regimen should follow doctor's advice.
Suitable for
Obese or overweight adults (BMI ≥30 kg/m² or ≥27 kg/m² with at least one weight-related comorbidity); healthy individuals requiring fat reduction and body shaping (under professional guidance).
Not suitable for
Individuals allergic to Survodutide or any excipients; individuals with personal or family history of medullary thyroid carcinoma; patients with multiple endocrine neoplasia syndrome type 2; pregnant and lactating women; patients with severe gastrointestinal disorders.
Ingredients
Survodutide (chemically synthesized peptide, molecular weight approx. 4.2 kDa)
Storage
Unopened: store at 2-8°C, protect from light; after first use: can be stored at 2-8°C for 30 days, do not freeze.
Shelf life
24 months
Product research FAQ
What is this product intended for?
It is supplied strictly for laboratory research and in-vitro studies, not for human consumption.
Is batch documentation available?
Available batch-specific Certificates of Analysis are listed in the COA section on this page.
How should the product be stored?
Follow the storage information shown on this page and the instructions supplied with the specific batch.
